We see various opportunities for distressed investing, both with respect to platform transactions as well as tuck-in transactions as certain businesses struggle to emerge from the COVID-19 pandemic

The authors have launched a new podcast called “Across the Table Podcast.” This podcast provides timely and relevant discussions with specialists and professionals of the healthcare private equity and finance industry. We’ll share latest developments, provide insight, identify issues and talk takeaways.

In the first episode, Mark Freedlander, Pittsburgh partner, discusses distressed investing in the healthcare sector, including an overview of the out-of-court and formal-bankruptcy process, common issues in distressed M&A and the importance of diligence. As the financial markets and economy negatively reacts to COVID-19, we are focusing our attention on opportunities for investing in distressed healthcare businesses. Successfully closing a transaction when the target is in financial distress presents some unique challenges. Whether the business has sought bankruptcy protection or is outside of the formal court process, there is opportunity for significantly cheaper deals, albeit with greater risk, available.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Amber McGraw Walsh Amber McGraw Walsh

Amber Walsh is the former Chairwoman of McGuireWoods LLP’s Healthcare department, one of the largest healthcare practices in the United States. She is also a recognized leader in promoting the advancement of women in the private equity sector. Focusing her practice on corporate…

Amber Walsh is the former Chairwoman of McGuireWoods LLP’s Healthcare department, one of the largest healthcare practices in the United States. She is also a recognized leader in promoting the advancement of women in the private equity sector. Focusing her practice on corporate healthcare transactional work and regulatory matters, she represents healthcare providers such as hospitals, health systems, dialysis facilities, multi- and single-specialty medical practices, specialty hospitals, ambulatory surgery centers, and a variety of healthcare industry entrepreneurs, in sales and acquisitions, joint ventures, general corporate matters, contracting, securities, and regulatory matters.

Photo of Geoff Cockrell Geoff Cockrell

Geoff is the immediate past chair of the firm’s private equity group where he served for over a decade. He also formerly served on the firm’s Board of Partners. He has a wide scope of experience in mergers and acquisitions and financing transactions.

Geoff is the immediate past chair of the firm’s private equity group where he served for over a decade. He also formerly served on the firm’s Board of Partners. He has a wide scope of experience in mergers and acquisitions and financing transactions. His mergers and acquisition experience, representing private equity sponsors, strategic purchasers and sellers extends across a diverse number of industries with a primary focus on healthcare provider services transactions. Geoff is a national contributor both at conferences and in publications on a wide array of issues unique to the private equity industry. He regularly contributes to Law360’s Healthcare and Private Equity sections, and is an author of The Healthcare Investor, a blog on healthcare finance topics.

Photo of Holly Buckley Holly Buckley

A national leader in healthcare M&A, private equity and finance transactions, Holly chairs McGuireWoods’ Healthcare Department, one of the largest healthcare practices in the United States. PE funds and healthcare clients — including hospitals, health systems, medical practices, physician-owned hospitals and ambulatory surgery…

A national leader in healthcare M&A, private equity and finance transactions, Holly chairs McGuireWoods’ Healthcare Department, one of the largest healthcare practices in the United States. PE funds and healthcare clients — including hospitals, health systems, medical practices, physician-owned hospitals and ambulatory surgery centers, among others — rely on her for structuring transactions, regulatory due diligence, affiliation agreements and compliance matters.